Search Results

Ponatinib (AP24534) Evaluation Sample  | 99.71%

APEXBIO TECHNOLOGY LLC

pan-BCR-ABL inhibitor,multi-kinase inhibitor TGF-β / Smad Signaling|Bcr-Abl

More Information Supplier Page

×

Ponatinib (AP24534)

Ponatinib (AP24534) 5mg  | 99.71%

APEXBIO TECHNOLOGY LLC

pan-BCR-ABL inhibitor,multi-kinase inhibitor TGF-β / Smad Signaling|Bcr-Abl

More Information Supplier Page

×

Ponatinib (AP24534)

Ponatinib (AP24534) 25mg  | 99.71%

APEXBIO TECHNOLOGY LLC

pan-BCR-ABL inhibitor,multi-kinase inhibitor TGF-β / Smad Signaling|Bcr-Abl

More Information Supplier Page

×

Ponatinib (AP24534)

PHA-793887 25mg  | 98%

APEXBIO TECHNOLOGY LLC

Pan-Cdk inhibitor Cell Cycle/Checkpoint|Cyclin-Dependent Kinases

More Information Supplier Page

×

PHA-793887

PHA-793887 5mg  | 98%

APEXBIO TECHNOLOGY LLC

Pan-Cdk inhibitor Cell Cycle/Checkpoint|Cyclin-Dependent Kinases

More Information Supplier Page

×

PHA-793887

PHA-793887 10mM (in 1mL DMSO)  | 98%

APEXBIO TECHNOLOGY LLC

Pan-Cdk inhibitor Cell Cycle/Checkpoint|Cyclin-Dependent Kinases

More Information Supplier Page

×

PHA-793887

AEE788 (NVP-AEE788) 50mg  | 98%

APEXBIO TECHNOLOGY LLC

EGFR/HER-2/VEGFR inhibitor JAK/STAT Signaling|EGFR

More Information Supplier Page

×

AEE788 (NVP-AEE788)

AEE788 (NVP-AEE788) 25mg  | 98%

APEXBIO TECHNOLOGY LLC

EGFR/HER-2/VEGFR inhibitor JAK/STAT Signaling|EGFR

More Information Supplier Page

×

AEE788 (NVP-AEE788)

PIK-93 25mg  | 98%

APEXBIO TECHNOLOGY LLC

PI3Kγ/PI4KIIIβ/PI3Kα inhibitor PI3K/Akt/mTOR Signaling|PI3K

More Information Supplier Page

×

PIK-93

PIK-93 100mg  | 98%

APEXBIO TECHNOLOGY LLC

PI3Kγ/PI4KIIIβ/PI3Kα inhibitor PI3K/Akt/mTOR Signaling|PI3K

More Information Supplier Page

×

PIK-93